InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Oliviero James F III, Chairman & CEO. Insider active across 2 companies, notably Checkpoint Therapeutics, Inc.. Cumulatively, 20 reports have been published. Breakdown: 0 buy · 10 sells. Total volume traded: €2.7m. History available since 31 January 2022. The latest transaction was filed on 12 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Oliviero James F III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
30,000 shares0Common StockSEC:0001104659-25-058916:0
3,759,929 sharesCOMMON STOCKSEC:0001104659-25-054690:0
15,090 shares@ US$4.041.6% of flowCOMMON STOCKSEC:0001104659-25-031813:0
9,233 shares@ US$3.410.9% of flowCOMMON STOCKSEC:0001104659-25-011656:0
1,500,000 shares0COMMON STOCK (RESTRICTED)SEC:0001104659-25-008258:0
602,167 shares@ US$3.8762.6% of flowCOMMON STOCKSEC:0001104659-24-130963:0
2,077,700 shares0COMMON STOCKSEC:0001104659-24-129525:0
24,610 shares@ US$2.051.3% of flowCOMMON STOCKSEC:0001104659-24-076442:0
30,000 shares0Common StockSEC:0001104659-24-071284:0
1,660,000 shares0COMMON STOCK (RESTRICTED)SEC:0001104659-24-065214:0
5,894 shares@ US$2.060.3% of flowCOMMON STOCKSEC:0001104659-24-030149:0
11,900 shares@ US$2.010.6% of flowCOMMON STOCKSEC:0001104659-24-010265:0
18,000 shares0Common StockSEC:0001104659-23-072607:0
250,000 shares0COMMON STOCK (RESTRICTED)SEC:0001104659-23-041761:0
5,548 shares@ US$4.650.7% of flowCOMMON STOCKSEC:0001104659-23-028603:0
10,261 shares@ US$4.771.3% of flowCOMMON STOCKSEC:0001104659-23-010771:0
3,817 shares@ US$6.7490.7% of flowCOMMON STOCKSEC:0001104659-23-003529:0
228,000 shares@ US$1.0922.1% of flowCOMMON STOCKSEC:0001104659-22-076976:0
302,777 shares@ US$3.1177.9% of flowCOMMON STOCKSEC:0001104659-22-049156:0
455,000 shares0COMMON STOCK (RESTRICTED)SEC:0001104659-22-010997:0
20 of 20 declarations
About Oliviero James F III
Oliviero James F III serves as President, Chief Executive Officer, and Board Member of Checkpoint Therapeutics, Inc. In this role, he leads the company's operations and develops strategies to achieve growth objectives. His expertise in the biopharmaceutical field is essential for Checkpoint, which focuses on developing innovative cancer treatments. Oliviero is committed to improving patient health through advanced therapeutic solutions.
